$OCGN Everything simply revolves around Covaxin getting approved for use in the USA. It doesn’t even have to be EUA. Of course it will take longer if it doesn’t. If they get approval in the US OCGN becomes a $20 a $40 stock and that is my PT. I’m bullish but want to keep expectations reasonable. We are talking the US market only and only 45% of that US revenue. IMO essentially this stock is somewhat “capped” as far as its “vaccine potential” Really need to see one of their other projects come to fruition.
5
6
6 Likes